Global position statement supporting a World Health Assembly resolution on steatotic liver disease
Nat Rev Gastroenterol Hepatol
.
2026 Jun;23(6):449-451.
doi: 10.1038/s41575-026-01201-z.
Authors
Jeffrey V Lazarus
1
2
,
Bruno Halpern
3
,
Peter E H Schwarz
4
5
,
Delfina Boudou
6
,
Harriette G C Van Spall
7
8
,
Veronica Miller
9
,
Ajay Duseja
10
Affiliations
1
City University of New York Graduate School of Public Health and Health Policy (CUNY SPH), New York, NY, USA. Jeffrey.Lazarus@isglobal.org.
2
Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain. Jeffrey.Lazarus@isglobal.org.
3
World Obesity Federation, London, UK.
4
International Diabetes Federation, Brussels, Belgium.
5
Prevention and Care of Diabetes, Medizinische Klinik und Poliklinik III, Universitätsklinikum Carl Gustav Carus, Dresden, Germany.
6
Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
7
Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
8
Population Health Research Institute, Hamilton, Ontario, Canada.
9
Forum for Collaborative Research, University of California Berkeley School of Public Health, Berkeley, CA, USA.
10
Department of Hepatology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
PMID:
41986753
DOI:
10.1038/s41575-026-01201-z
No abstract available